EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Cancer Risk Prediction Using Machine Learning for Supporting Early Cancer Diagnosis in Symptomatic Patients: A Systematic Review of Model Types

Krebsrisikovorhersage mit Machine Learning zur Unterstützung der frühen Krebsdiagnose bei symptomatischen Patient:innen: systematische Übersicht zu Modelltypen

Flavia Pennisi iD, Stefania Borlini, Hannah Harrison, Rita Cuciniello, Anna Carole D'Amelio, Matthew Barclay, Giovanni Emanuele Ricciardi, Georgios Lyratzopoulos, Cristina Renzi

Cancer Medicine · 2025-12 · 14 (24)

DOI: 10.1002/cam4.71463 ↗

Auf einen Blick

Die systematische Übersicht zu 34 Studien zeigt variable Leistungen von ML-Modellen zur Krebsrisikovorhersage bei symptomatischen Patient:innen. Die Evidenz ist heterogen und häufig durch Bias begrenzt.

Fragestellung

Welche Evidenz gibt es für ML-Modelle, die das Krebsrisiko auf Basis von Symptomen und weiteren Patient:innenmerkmalen schätzen?

Methode

Systematische Übersicht von Studien aus 2014–2024 in MEDLINE, Scopus und EMBASE; 34 eingeschlossene Studien; Bewertung mit QUADAS-AI und TRIPOD.

Ergebnisse

34 Studien. Häufig untersucht: Lunge (9 Studien), Mesotheliom (7) und gastrointestinale Krebsarten (4). AUC in der Validierung: 0,60 bis 1. Beste Leistung bei Random Forest, SVM, Decision Tree und Multilayer Perceptron.

Einschränkungen

94,1 % der Studien hatten ein hohes Bias-Risiko für den Index-Test; die Evidenz war heterogen und oft unvollständig berichtet.

Schlussfolgerung der Autor:innen

ML-Modelle zeigen Potenzial für das Management komplexer Daten zur Krebsrisikovorhersage. Weitere Validierung und Bewertungen der Praxisleistung sind vor klinischem Einsatz nötig.

Kernaussagen

  • AUC in der Validierung: 0,60 bis 1
  • 94,1 % mit hohem Bias-Risiko für den Index-Test
  • Weitere Validierung vor klinischem Einsatz nötig

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Cancer Medicine, published online on 2025-12-13. Written by Flavia Pennisi and 8 co-authors. Institution: PhD National Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Foren…. Major MEDLINE topics: Machine Learning, Early Detection of Cancer, Neoplasms. Cited 21 times so far (Crossref); 97 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cancer Research UK.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Predictive models could support clinicians in identifying patients who may benefit from cancer investigations. We aimed to examine published evidence on machine learning models (ML) developed to estimate cancer risk based on symptoms and other patient characteristics.

Methods

Using MEDLINE, Scopus, and EMBASE, we performed a systematic review of studies published in 2014–2024, which included data on signs/symptoms for cancer risk prediction. We used the QUADAS‐AI tools to assess study quality. We performed a quantitative synthesis of diagnostic performance, including accuracy, sensitivity, specificity, area under the curve (AUC). Adherence to TRIPOD guidelines was assessed.

Results

Among the 5646 initially identified articles, 34 met inclusion criteria. Included studies most frequently examined lung ( n = 9 studies), mesothelioma ( n = 7), and gastrointestinal cancers ( n = 4) and used hospital electronic health records ( n = 8) or publicly available online datasets ( n = 13). In addition to signs/symptoms ( n = 34), most models included sociodemographic characteristics ( n = 27) and lifestyle factors ( n = 20). In 70% of studies, internal validation was performed. ML models demonstrated variable performance, with AUC values ranging from 0.60 to 1 during validation. Random Forest, Support Vector Machine, Decision Tree, and Multilayer Perceptron showed the best predictive performance. Most of the studies (94.1%) had a high risk of bias for the index test.

Conclusion

ML models have been reported to demonstrate potential in managing complex data for cancer risk prediction. However, the current evidence is heterogeneous and frequently limited by bias and incomplete reporting. Further validation and thorough assessments of real‐world performance are necessary before these models can be considered reliable for clinical use. Trial Registration International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42024548088

Subjects

MeSH terms (MEDLINE)

Machine LearningEarly Detection of CancerNeoplasmsHumansRisk Assessment

Author keywords

artificial intelligencecancerearly detection of cancermachine learningsigns and symptoms

Authors and institutions

  • PhD National Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
  • School of Medicine, Università Vita-Salute San Raffaele, Milano, Italy.
  • Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Research Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.

ORCID profiles: Flavia Pennisi

Funding

  • Cancer Research UK

Cite

APA

Pennisi, F., Borlini, S., Harrison, H., Cuciniello, R., D'Amelio, A. C., Barclay, M., Ricciardi, G. E., Lyratzopoulos, G., & Renzi, C. (2025). Cancer Risk Prediction Using Machine Learning for Supporting Early Cancer Diagnosis in Symptomatic Patients: A Systematic Review of Model Types. Cancer Medicine, 14(24). https://doi.org/10.1002/cam4.71463

Vancouver

Pennisi F, Borlini S, Harrison H, Cuciniello R, D'Amelio AC, Barclay M, et al. Cancer Risk Prediction Using Machine Learning for Supporting Early Cancer Diagnosis in Symptomatic Patients: A Systematic Review of Model Types. Cancer Medicine. 2025;14(24). doi:10.1002/cam4.71463

BibTeX
@article{Pennisi2025,
  author = {Pennisi, Flavia and Borlini, Stefania and Harrison, Hannah and Cuciniello, Rita and D'Amelio, Anna Carole and Barclay, Matthew and Ricciardi, Giovanni Emanuele and Lyratzopoulos, Georgios and Renzi, Cristina},
  title = {Cancer Risk Prediction Using Machine Learning for Supporting Early Cancer Diagnosis in Symptomatic Patients: A Systematic Review of Model Types},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {24},
  doi = {10.1002/cam4.71463}
}
Start for free →